BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-08 5:00 pm Purchase | 2021-07-06 | 13G | Calithera Biosciences, Inc. CALA | BIOTECHNOLOGY VALUE FUND L P | 372,617 10.100% | 154,555 (+70.88%) | Filing |
| 2021-02-11 5:25 pm Sale | 2020-12-31 | 13G | Calithera Biosciences, Inc. CALA | BIOTECHNOLOGY VALUE FUND L P | 218,062 6.200% | -136,470 (-38.49%) | Filing |
| 2020-05-26 4:56 pm Sale | 2020-05-21 | 13G | Calithera Biosciences, Inc. CALA | BIOTECHNOLOGY VALUE FUND L P | 354,532 10.100% | -123,450 (-25.83%) | Filing |
| 2020-02-14 2:44 pm Purchase | 2019-12-31 | 13G | Calithera Biosciences, Inc. CALA | BIOTECHNOLOGY VALUE FUND L P | 477,982 15.100% | 140,458 (+41.61%) | Filing |